Research and Markets has announced the addition of the "Global Active Pharmaceutical Ingredients Market 2017-2021" report to their offering.
The report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is growing influence of key markets. The influence of vendors especially from APAC and to some extent from the Eastern Europe is increasing. India, China, South Korea, and Taiwan are expected to emerge as the leading markets for generics owing to the low production cost. Expertise in process chemistry and low manufacturing and labor costs are the major factors that have contributed to the increased competence of vendors in these countries.
According to the report, one of the major drivers for this market is strong focus on HPAPI. The demand for HPAPIs is growing considerably during the forecast period due to the increase in the application of targeted therapies for the treatment of diseases. The sustained innovations since 2015 are expected to sustain the market growth in future. The number of drug approvals during 2015 was the highest in recent years. This success is driving the funding for new materials, which is, thereby increasing the R&D of new HPAPIs.